132 related articles for article (PubMed ID: 36062762)
21. Dual-Energy Computed Tomography-Based Radiomics to Predict Peritoneal Metastasis in Gastric Cancer.
Chen Y; Xi W; Yao W; Wang L; Xu Z; Wels M; Yuan F; Yan C; Zhang H
Front Oncol; 2021; 11():659981. PubMed ID: 34055627
[TBL] [Abstract][Full Text] [Related]
22. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
[TBL] [Abstract][Full Text] [Related]
23. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
Front Oncol; 2022; 12():843991. PubMed ID: 35692757
[TBL] [Abstract][Full Text] [Related]
24. Total Lesion Glycolysis Ratio in Positron Emission Tomography/Computed Tomography Images During Neoadjuvant Chemotherapy Can Predict Pathological Tumor Regression Grade and Prognosis in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus.
Sonoda A; Yoshida N; Shiraishi S; Horinouchi T; Tokunaga R; Harada K; Iwatsuki M; Nagai Y; Baba Y; Iwagami S; Miyamoto Y; Baba H
Ann Surg Oncol; 2021 Jan; 28(1):167-174. PubMed ID: 32588261
[TBL] [Abstract][Full Text] [Related]
25. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Preoperative Radiomics Signature on the Survival of Breast Cancer Patients With Residual Tumors After NAC.
Zhang L; Jiang X; Xie X; Wu Y; Zheng S; Tian W; Xie X; Li L
Front Oncol; 2020; 10():523327. PubMed ID: 33614472
[TBL] [Abstract][Full Text] [Related]
27. A CT-based radiomics signature for evaluating tumor infiltrating Treg cells and outcome prediction of gastric cancer.
Gao X; Ma T; Bai S; Liu Y; Zhang Y; Wu Y; Li H; Ye Z
Ann Transl Med; 2020 Apr; 8(7):469. PubMed ID: 32395513
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
Hayashi M; Fujita T; Matsushita H
Eur J Surg Oncol; 2021 Aug; 47(8):1996-2003. PubMed ID: 33353828
[TBL] [Abstract][Full Text] [Related]
29. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
30. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
[TBL] [Abstract][Full Text] [Related]
31. Radiomics Analysis of PET and CT Components of
Wang X; Lu Z
Front Oncol; 2021; 11():638124. PubMed ID: 33928029
[TBL] [Abstract][Full Text] [Related]
32. Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy.
Gao X; Zhang Y; Yuan F; Ding B; Ma Q; Yang W; Yan J; Du L; Wang B; Yan F; Sedlmair M; Pan Z; Zhang H
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2207-2218. PubMed ID: 30094537
[TBL] [Abstract][Full Text] [Related]
33. CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.
Sun KY; Hu HT; Chen SL; Ye JN; Li GH; Chen LD; Peng JJ; Feng ST; Yuan YJ; Hou X; Wu H; Li X; Wu TF; Wang W; Xu JB
BMC Cancer; 2020 May; 20(1):468. PubMed ID: 32450841
[TBL] [Abstract][Full Text] [Related]
34. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
[TBL] [Abstract][Full Text] [Related]
35. Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer.
Baksh K; Prithviraj G; Kim Y; Hoffe S; Shridhar R; Coppola D; Centeno B; Pimiento J; Meredith K; Almhanna K
Am J Clin Oncol; 2018 Mar; 41(3):254-258. PubMed ID: 26703814
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
37. Integrating Tumor and Nodal Radiomics to Predict the Response to Neoadjuvant Chemotherapy and Recurrence Risk for Locally Advanced Gastric Cancer.
Han S; Han X; Song Y; Liu R; Wang H; Zhang Z; Yu B; Li Z; Liu S
Curr Med Imaging; 2024 May; ():. PubMed ID: 38798223
[TBL] [Abstract][Full Text] [Related]
38. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer.
Jiang Y; Chen C; Xie J; Wang W; Zha X; Lv W; Chen H; Hu Y; Li T; Yu J; Zhou Z; Xu Y; Li G
EBioMedicine; 2018 Oct; 36():171-182. PubMed ID: 30224313
[TBL] [Abstract][Full Text] [Related]
39. Radiomics Analysis of Iodine-Based Material Decomposition Images With Dual-Energy Computed Tomography Imaging for Preoperatively Predicting Microsatellite Instability Status in Colorectal Cancer.
Wu J; Zhang Q; Zhao Y; Liu Y; Chen A; Li X; Wu T; Li J; Guo Y; Liu A
Front Oncol; 2019; 9():1250. PubMed ID: 31824843
[No Abstract] [Full Text] [Related]
40. Enhanced CT-based radiomics predicts pathological complete response after neoadjuvant chemotherapy for advanced adenocarcinoma of the esophagogastric junction: a two-center study.
Huang W; Li L; Liu S; Chen Y; Liu C; Han Y; Wang F; Zhan P; Zhao H; Li J; Gao J
Insights Imaging; 2022 Aug; 13(1):134. PubMed ID: 35976518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
